Boudreau Helen M 4
4 · Cara Therapeutics, Inc. · Filed Aug 4, 2023
Insider Transaction Report
Form 4
Boudreau Helen M
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-08-02+155,747→ 155,747 totalExercise: $3.09Exp: 2033-08-02→ Common Stock (155,747 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in twelve (12) equal quarterly installments beginning on August 2, 2023 such that the option will be fully vested and exercisable on August 2, 2026, subject to the Reporting Person's continued service to the Issuer on each such date.